13F HOLDINGS REPORT
REGENERON PHARMACEUTICALS, INC.
Quarter ended Q1 2025 · Filed May 2, 2025 · Accession 0001104659-25-044118
Total Value
$1.23B
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Alnylam Pharmaceuticals, Inc. | ALNY | 4,444,445 | $1.20B | 97.23% |
| 2 | Intellia Therapeutics, Inc. | NTLA | 3,702,995 | $26.3M | 2.13% |
| 3 | 2seventy Bio, Inc. | 901384107 | 1,254,827 | $6.2M | 0.50% |
| 4 | Adverum Biotechnologies, Inc. | 00773U207 | 180,909 | $790,572 | 0.06% |
| 5 | Adicet Bio, Inc. | ACET | 968,183 | $730,978 | 0.06% |
| 6 | Bluebird Bio, Inc. | 09609G209 | 21,000 | $102,480 | 0.01% |